Alison C Lynch, Andrea N Weber, Suzy Hedden, Sayeh Sabbagh, Stephan Arndt, Laura Acion
BACKGROUND: Opioid use disorder (OUD), a chronic disease, is a major public health problem. Despite availability of effective treatment, too few people receive it and treatment retention is low. Understanding barriers and facilitators of treatment access and retention is needed to improve outcomes for people with OUD.
OBJECTIVES: To assess 3-month outcomes pilot data from a patient-centered OUD treatment program in Iowa, USA, that utilized flexible treatment requirements and prioritized engagement over compliance.
METHODS: Forty patients (62.5% female: mean age was 35.7 years, SD 9.5) receiving medication, either buprenorphine or naltrexone, to treat OUD were enrolled in an observational study. Patients could select or decline case management, counseling, and peer recovery groups. Substance use, risk and protective factors, and recovery capital were measured at intake and 3 months.
RESULTS: Most participants reported increased recovery capital. The median Assessment of Recovery Capital (ARC) score went from 37 at enrollment to 43 (p < 0.01). Illegal drug use decreased, with the median days using illegal drugs in the past month dropping from 10 to 0 (p < 0.001). Cravings improved: 29.2% reported no cravings at intake and 58.3% reported no cravings at 3 months (p < 0.001). Retention rate was 92.5% at 3 months. Retention rate for participants who were not on probation/parole was higher (96.9%) than for those on probation/parole (62.5%, p = 0.021).
CONCLUSION: This study shows preliminary evidence that a care model based on easy and flexible access and strategies to improve treatment retention improves recovery capital, reduces illegal drug use and cravings, and retains people in treatment.
J Addict Dis. 2016;35(1):22-35
[PMID:
26467975]
Subst Abuse Treat Prev Policy. 2015 Jan 26;10:3
[PMID:
25619263]
J Subst Abuse Treat. 2019 Jun;101:50-54
[PMID:
31174713]
Subst Abuse. 2018 Feb 28;12:1178221818760551
[PMID:
29531472]
Counselor (Deerfield Beach). 2005 Apr;6(2):12-25
[PMID:
30662372]
J Addict Med. 2020 Mar/Apr;14(2S Suppl 1):1-91
[PMID:
32511106]
JAMA. 2002 Oct 9;288(14):1775-9
[PMID:
12365965]
Addiction. 2017 Mar;112(3):466-467
[PMID:
28168794]
Addiction. 2006 Dec;101(12):1741-51
[PMID:
17156173]
J Biomed Inform. 2009 Apr;42(2):377-81
[PMID:
18929686]
J Consult Clin Psychol. 2014 Dec;82(6):964-72
[PMID:
25090043]
Subst Abuse Treat Prev Policy. 2020 Jan 20;15(1):7
[PMID:
31959189]
J Epidemiol Community Health. 2019 May;73(5):377-378
[PMID:
30723087]
J Gen Intern Med. 2005 Nov;20(11):1038-41
[PMID:
16307630]
Arch Gen Psychiatry. 1985 Apr;42(4):375-9
[PMID:
3977555]
Subst Use Misuse. 2008;43(1):27-54
[PMID:
18189204]
Fam Process. 1989 Jun;28(2):239-49
[PMID:
2659389]
Addiction. 2020 Sep;115(9):1683-1694
[PMID:
32096302]
BMC Health Serv Res. 2018 Oct 3;18(1):753
[PMID:
30285718]
JAMA Psychiatry. 2021 May 1;78(5):562-564
[PMID:
33270086]
J Subst Abuse Treat. 2021 Mar;122:108219
[PMID:
33353790]
Drug Alcohol Depend. 2000 Feb 1;58(1-2):165-72
[PMID:
10669068]
J Dual Diagn. 2014;10(2):60-7
[PMID:
24976801]
Indian J Psychiatry. 2007 Oct;49(4):256-61
[PMID:
20680137]
Ann N Y Acad Sci. 2012 Feb;1248:1-17
[PMID:
22172057]
J Subst Abuse Treat. 2014 Mar;46(3):356-61
[PMID:
24238714]
Drug Alcohol Rev. 2013 Mar;32(2):187-94
[PMID:
22882622]
Soc Work Public Health. 2013;28(3-4):388-406
[PMID:
23731427]
Am J Psychiatry. 2017 Aug 1;174(8):738-747
[PMID:
27978771]
J Subst Abuse Treat. 2013 Mar;44(3):256-63
[PMID:
22898042]
Exp Clin Psychopharmacol. 2008 Apr;16(2):132-43
[PMID:
18489017]
J Addict Med. 2012 Mar;6(1):68-76
[PMID:
22105061]
JAMA. 2015 Apr 28;313(16):1636-44
[PMID:
25919527]
Am J Psychiatry. 2005 Feb;162(2):340-9
[PMID:
15677600]
Addiction. 2014 Jan;109(1):79-87
[PMID:
23961726]
JAMA Health Forum. 2020 Oct 1;1(10):e201318
[PMID:
36218556]
Int J Qual Stud Health Well-being. 2014 Mar 13;9:23698
[PMID:
24646474]
Am J Psychiatry. 2008 Jul;165(7):881-8
[PMID:
18450927]
J Biomed Inform. 2019 Jul;95:103208
[PMID:
31078660]
J Policy Anal Manage. 2019;38(2):366-93
[PMID:
30882195]
J Subst Abuse Treat. 2021 Jan;120:108155
[PMID:
33298297]
Int J Environ Res Public Health. 2009 Nov;6(11):2822-32
[PMID:
20049227]
Am J Drug Alcohol Abuse. 2014 Mar;40(2):163-9
[PMID:
24521036]
Am J Public Health. 2011 Apr;101(4):737-44
[PMID:
21330586]
Am J Drug Alcohol Abuse. 2020 May 3;46(3):273-288
[PMID:
31809217]
